ad

Symbiotec Pharmalab (SYMBIOTEC) Share Price Hits Fresh 52-Week High of Rs 1,649.00

16 Nov 2026 • 11:44 am

Symbiotec Pharmalab (SYMBIOTEC) Share Price Hits Fresh 52-Week High of Rs 1,649.00
SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) share price reached a fresh 52-week high of Rs 1,649 today and later stood at Rs 1,604.5, down 0.59% from the previous close. Market cap was Rs 10,371.26 crore.

The Symbiotec Pharmalab share price is Rs 1,604.50 as of 16 November 2026 at 11:37 AM IST, down 0.59% from the previous close of Rs 1,614.05. The stock touched a fresh 52-week high of Rs 1,649.00 earlier today, and Symbiotec Pharmalab now carries a market capitalisation of Rs 10,371.26 crore.

This Symbiotec Pharmalab share price update rests on the fresh 52-week high event confirmed by the Univest 52-week-high screener, and the stock now appears on the 52 Week High Stocks list. The price move is confirmed in Univest data; a company-specific reason has not been established.

Symbiotec Pharmalab Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 1,604.5
Previous Close Rs 1,614.05
Today's Move Rs -9.55 (-0.59%)
Open Rs 1,608.05
High Rs 1,649
Low Rs 1,596
Market Capitalisation Rs 10,371.26 crore

Readers following Symbiotec Pharmalab stock news can watch the day range of Rs 1,596.00 to Rs 1,649.00, the valuation against pharma industry peers, and the Sep 2026 quarter revenue of Rs 279.93 crore, all covered below.

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) traded at Rs 1,604.5 versus the previous close of Rs 1,614.05, a fall of 0.59%. The stock opened at Rs 1,608.05, reached a high of Rs 1,649 and touched a low of Rs 1,596.

What happened to the Symbiotec Pharmalab share price today? The stock opened at Rs 1,608.05, touched a low of Rs 1,596.00 and a fresh 52-week high of Rs 1,649.00, and last traded at Rs 1,604.50, a fall of Rs 9.55 or 0.59% from the previous close of Rs 1,614.05.

The one-year high of Rs 1,649.00 is also today's intraday high, so the Symbiotec Pharmalab 52 week high and the day high are the same level. The stock now trades Rs 44.50 below that peak, which places the latest Symbiotec Pharmalab share price in the lower part of the day's range.

The opening price of Rs 1,608.05 was below the previous close of Rs 1,614.05, and the day high of Rs 1,649.00 sits Rs 34.95 above the previous close. This Symbiotec Pharmalab stock performance reading is a confirmed price fact, not a forecast, and it does not point to a reason for the move.

For readers comparing the Symbiotec Pharmalab share price with the day's range, the latest price is Rs 8.50 above the day low of Rs 1,596.00, inside a total band of Rs 53.00 between the low and the high. That is a simple way to read where the stock sits within today's price action.

Univest tracks every fresh 52-week high through its screener, which is why the Symbiotec Pharmalab share price live reading today is classed as a confirmed event. The sections below turn to valuation and fundamentals to place the move in context.

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) Fundamental Analysis

Metric Value
Market Capitalisation Rs 10,371.26 crore
P/E Ratio 94.37x
P/B Ratio 7.62x
ROE 11.22%
ROCE 12.41%
EPS Rs 17.1
Book Value Per Share Rs 211.8
Dividend Yield 0%

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) fundamental metrics show P/E 94.37x, P/B 7.62x, ROE 11.22%, ROCE 12.41%. These ratios show where the company stands today and are not a call to buy or sell.

SYMBIOTEC PHARMALAB LTD has a market capitalisation of Rs 10,371.26 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 94.37x, P/B at 7.62x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.22% and ROCE of 12.41%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 17.1, book value per share of Rs 211.8, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.49x, median ROE of 10.97%, median ROCE of 12.7%. Together they describe the fundamental backdrop without implying a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 94.37x
Benchmark Median P/E 30.49x
Benchmark Average P/E 51.97x
Benchmark P/E Range 2.6x to 1,177x
Company P/B Ratio 7.62x
Benchmark Median P/B 2.88x
Company ROE 11.22%
Benchmark Median ROE 10.97%
Company ROCE 12.41%
Benchmark Median ROCE 12.7%
Company Market Capitalisation Rs 10,371.26 crore
Benchmark Median Market Cap Rs 677.13 crore

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a P/E ratio of 94.37x, which is above the benchmark median of 30.49x, a difference of +209.51%. A P/E difference of this kind is a reference point rather than a recommendation.

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a ROE of 11.22%, which is above the benchmark median of 10.97%, a difference of +2.28%. SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a ROCE of 12.41%, which is below the benchmark median of 12.7%, a difference of -2.28%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Blue Jet Healthcare Ltd. BLUEJET 10,201.96 35.76 4.44 19.88 27.18
Procter & Gamble Health Ltd. PGHL 9,666.98 25.45 14.69 62.18 84.86
Sequent Scientific Ltd. VIYASH 11,275.21 48.48 3.56 9.06 13.1
Strides Pharma Science Ltd. STAR 9,350.76 15.16 2.74 20.31 18.57
Akums Drugs & Pharmaceuticals Ltd. AKUMS 11,655.81 32.04 3.33 8.06 14.77

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a P/E ratio of 94.37x compared with the displayed peer median of 32.04x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.22% compares with a peer median of 19.88% across the companies shown in the table. ROCE stood at 12.41% versus the displayed peer median of 18.57%, providing a capital-efficiency comparison. SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a market capitalisation of Rs 10,371.26 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching Symbiotec Pharmalab

  • The stock touched a fresh 52-week high of Rs 1,649.00 today.
  • The Symbiotec Pharmalab share price is Rs 1,604.50, down 0.59% from the previous close of Rs 1,614.05.
  • P/E of 94.37 is above the industry median of 30.49 and the industry average of 51.97.
  • ROE of 11.22% is above the industry median of 10.97% and the average of 4.67%.
  • Market cap of Rs 10,371.26 crore is above the industry median of Rs 677.13 crore.

About Symbiotec Pharmalab

Symbiotec Pharmalab trades on the NSE under the symbol SYMBIOTEC. Univest classifies the company in the Healthcare sector and the Pharmaceuticals & Drugs industry, which is the group used for the benchmark comparisons in this article. The latest quarterly revenue is Rs 279.93 crore for the Sep 2026 quarter.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

What is the Symbiotec Pharmalab share price today?

Ans. As of 16 November 2026 at 11:37 AM IST, the Symbiotec Pharmalab share price is Rs 1,604.50, down Rs 9.55 or 0.59% from the previous close of Rs 1,614.05. It trades on the NSE as SYMBIOTEC.

What is the Symbiotec Pharmalab 52-week high?

Ans. The fresh 52-week high for Symbiotec Pharmalab is Rs 1,649.00, touched today. This one-year high is also the day high, and the stock now trades Rs 44.50 below that peak at Rs 1,604.50.

Why is the Symbiotec Pharmalab share price in focus today?

Ans. The price move is confirmed in Univest data; a company-specific reason has not been established. The fresh 52-week high of Rs 1,649.00 is a verified fact, while the cause of the move is not stated.

What is the market cap of Symbiotec Pharmalab?

Ans. The market capitalisation of Symbiotec Pharmalab is Rs 10,371.26 crore. In the Pharmaceuticals & Drugs benchmark of 203 companies, that is above the median of Rs 677.13 crore and below the average of Rs 14,561.14 crore.

What is the Symbiotec Pharmalab P/E ratio compared with its industry?

Ans. The Symbiotec Pharmalab P/E ratio is 94.37 against an industry median of 30.49 and an average of 51.97. The P/B ratio is 7.62 against a median of 2.88, so both multiples sit above the median.

What are the ROE and ROCE of Symbiotec Pharmalab?

Ans. Symbiotec Pharmalab has an ROE of 11.22% and an ROCE of 12.41%. The industry medians are 10.97% for ROE and 12.70% for ROCE, so ROE sits above the median and ROCE sits slightly below it.

What are the EPS, book value and dividend yield of Symbiotec Pharmalab?

Ans. EPS is Rs 17.10, which shows earnings attributable to each share. Book value per share is Rs 211.80, and the dividend yield is 0%, a historical payout measure relative to the current price.

How does Symbiotec Pharmalab compare with its peers?

Ans. Against five listed peers, Symbiotec Pharmalab has a P/E of 94.37, above Sequent Scientific at 48.48 and every other peer shown. Its market cap of Rs 10,371.26 crore is larger than three of the five peers.

Track Symbiotec Pharmalab Share Price on Univest

Use SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Users can track the live Symbiotec Pharmalab share price, fundamental ratios, 52-week levels and market insights on Univest. Univest also keeps the peer comparison and sector benchmarks together, so readers can follow the stock after this 52-week high event. This article is for information only and carries no recommendation.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5
ad

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited

Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003

Write to us : support@univest.in, compliance@univest.in

Verify on SEBI registry →

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down